logo

Myovant Sciences Ltd (MYOV)



Trade MYOV now with
  Date
  Headline
7/20/2021 2:13:39 AM Myovant Sciences: European Commission Approves Marketing Authorization Application For RYEQO
5/11/2021 7:14:34 AM Myovant Q4 Loss/Shr $0.89 Vs Loss $0.73 Last Year
4/12/2021 7:01:57 AM Myovant, Pfizer: First Participant Dosed In Phase 3 SERENE Study
4/5/2021 7:07:52 AM Myovant Sciences Appoints Lauren Merendino As Chief Commercial Officer
3/24/2021 6:39:10 AM Myovant Sciences, Pfizer Announce Positive Data From Phase 3 LIBERTY Randomized Withdrawal Study
1/26/2021 6:58:36 AM Myovant, Pfizer Announce Positive One-Year Data From Phase 3 SPIRIT Extension Study
1/4/2021 7:00:19 AM Myovant Appoints David Marek CEO
12/28/2020 6:33:15 AM Myovant Sciences, Pfizer Partner To Develop Relugolix In Oncology And Women's Health
12/16/2020 8:43:03 AM Myovant Sciences Reports New Employment Inducement Grants Under NYSE Rule 303A.08